These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 9754825)

  • 1. Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning.
    Nielsen MF; Dinneen S; Basu A; Basu R; Alzaid A; Rizza RR
    Diabetologia; 1998 Sep; 41(9):1064-72. PubMed ID: 9754825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
    Trümper BG; Reschke K; Molling J
    Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
    Ranganath LR; Beety JM; Morgan LM
    Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the glycaemic index of an evening meal on substrate oxidation following breakfast and during exercise the next day in healthy women.
    Stevenson E; Williams C; Nute M; Humphrey L; Witard O
    Eur J Clin Nutr; 2008 May; 62(5):608-16. PubMed ID: 17440522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycemic index on whole-body substrate oxidation in obese women.
    Díaz EO; Galgani JE; Aguirre CA; Atwater IJ; Burrows R
    Int J Obes (Lond); 2005 Jan; 29(1):108-14. PubMed ID: 15505637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDM.
    Dinneen S; Alzaid A; Miles J; Rizza R
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E595-603. PubMed ID: 7733257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans.
    Butler P; Kryshak E; Rizza R
    Am J Physiol; 1991 Apr; 260(4 Pt 1):E513-20. PubMed ID: 2018116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal.
    McMahon M; Marsh H; Rizza R
    J Clin Endocrinol Metab; 1989 Mar; 68(3):647-53. PubMed ID: 2645312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
    Dinneen S; Alzaid A; Miles J; Rizza R
    J Clin Invest; 1993 Nov; 92(5):2283-90. PubMed ID: 8227343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep restriction increases free fatty acids in healthy men.
    Broussard JL; Chapotot F; Abraham V; Day A; Delebecque F; Whitmore HR; Tasali E
    Diabetologia; 2015 Apr; 58(4):791-8. PubMed ID: 25702040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity.
    Van Cauter EV; Polonsky KS; Blackman JD; Roland D; Sturis J; Byrne MM; Scheen AJ
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1797-805. PubMed ID: 7989487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.
    Van Cauter E; Blackman JD; Roland D; Spire JP; Refetoff S; Polonsky KS
    J Clin Invest; 1991 Sep; 88(3):934-42. PubMed ID: 1885778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon on glucose tolerance and insulin sensitivity.
    Koivisto VA; Pelkonen R; Cantell K
    Diabetes; 1989 May; 38(5):641-7. PubMed ID: 2653935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.